These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36394173)

  • 1. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit.
    Polat EC; Koc A; Demirkan K
    J Clin Pharm Ther; 2022 Dec; 47(12):2287-2294. PubMed ID: 36394173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury.
    Williams VL; Smithburger PL; Imhoff AN; Groetzinger LM; Culley CM; Burke CX; Murugan R; Lamberty PE; Mahmud M; Benedict NJ; Kellum JA; Kane-Gill SL
    Ann Pharmacother; 2023 Apr; 57(4):408-415. PubMed ID: 35962583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pharmacist intervention in reducing vancomycin-associated acute kidney injury: A systematic review and meta-analysis.
    Kunming P; Xiaotian J; Qing X; Chenqi X; Xiaoqiang D; Qian Zhou L
    Br J Clin Pharmacol; 2023 Feb; 89(2):526-535. PubMed ID: 35285970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of goal-directed therapy bundle based on PiCCO parameters to the prevention and treatment of acute kidney injury in patients after cardiopulmonary bypass cardiac operation: a prospective observational study].
    Pan C; Liu J; Hu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):731-736. PubMed ID: 31315732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
    Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
    BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handling drug-related problems in rehabilitation patients: a randomized study.
    Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
    Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
    Saokaew S; Maphanta S; Thangsomboon P
    Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
    Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
    Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
    Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS
    Paediatr Drugs; 2017 Feb; 19(1):59-67. PubMed ID: 27943125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
    Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
    BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study.
    Kim MH; Koh SO; Kim EJ; Cho JS; Na SW
    BMC Anesthesiol; 2015; 15():23. PubMed ID: 25780349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit.
    Stoops C; Stone S; Evans E; Dill L; Henderson T; Griffin R; Goldstein SL; Coghill C; Askenazi DJ
    J Pediatr; 2019 Dec; 215():223-228.e6. PubMed ID: 31761141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study.
    Ayhan YE; Karakurt S; Sancar M
    J Clin Pharm Ther; 2022 Nov; 47(11):1867-1874. PubMed ID: 36196779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K; Ramireddy K; Madison G; Turco T; Lui M
    J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.
    Garzotto F; Piccinni P; Cruz D; Gramaticopolo S; Dal Santo M; Aneloni G; Kim JC; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
    Blood Purif; 2011; 31(1-3):159-71. PubMed ID: 21228585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial.
    Yalçın N; Kaşıkcı M; Çelik HT; Allegaert K; Demirkan K; Yiğit Ş
    Front Pharmacol; 2023; 14():1242779. PubMed ID: 37645440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.